Learn More
Medchemexpress LLC ABT-737-d8 | 1217686-68-4 | 99.1% | C42H37D8ClN6O5S2 | 1 MG

Supplier: Medchemexpress LLC HY50907S1MG
ABT-737-d8 is a deuterium labeled ABT-737, a potent BH3 mimetic that inhibits Bcl-2, Bcl-xL, and Bcl-w. It induces the disruption of the BCL-2/BAX complex and BAK-dependent but BIM-independent activation of the intrinsic apoptotic pathway. ABT-737 also induces autophagy and has potential for acute myeloid leukemia (AML) research. Deuteration can affect pharmacokinetic and metabolic profiles of drugs.
- Used as a tracer for quantitative analysis
- Can be an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.